# Alethio Therapeutics funding: rounds and investors > Alethio Therapeutics has raised $98M across 3 rounds since 2021. Investors include RA Capital Management, Sofinnova Partners and Oxford Science Enterprises. Source: https://millionrounds.com/company/alethio-therapeutics (Millionrounds; every figure on the page links to its filing or article) United Kingdom · [Series A startup](https://millionrounds.com/companies) # Who invested in *Alethio Therapeutics* 3 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it. Biotech Healthcare Raised this month Follow Alethio Therapeutics and see its new rounds in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Fcompany%2Falethio-therapeutics) Funding summary Updated 7 Nov 2026 **$98M** raised across 3 rounds since 2021, from 4 sources **$4.4M** Seed **$3.4M** Seed **$90M** Series A - **Latest round:** Series A, $90M Nov 2026 - **Led by:** RA Capital Management and Sofinnova Partners - **Step-up i:** 26.2× - **Investors:** 5 (2 led) See who backed them ## The funding story Each circle is a round, placed by date and sized by amount. The line above is the running total. 2022 2023 2024 2025 2026 **$4.4M** Seed **$3.4M** Seed **$90M** Series A - **First round:** Seed, $4.4M - **Biggest round:** $90M - **Usual gap between rounds:** 3.3 years ## The rounds - **Nov 2026** Series A **$90M** *5 new* [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) Lead [Sofinnova Partners](https://millionrounds.com/fund/sofinnova-partners) Lead [Oxford Science Enterprises](https://millionrounds.com/fund/oxford-science-enterprises) [University of Oxford](https://millionrounds.com/fund/university-of-oxford) [Cancer Research Horizons](https://millionrounds.com/fund/cancer-research-ho) Reported by Google News search and 1 other - **Jul 2023** Seed **$3.4M** No investor was named in the report. Shares issued, filed with Companies House (SH01); no report of this raise yet - **Dec 2021** Seed **$4.4M** No investor was named in the report. Shares issued, filed with Companies House (SH01); no report of this raise yet ## Funding filed with regulators Alethio Therapeutics filed 2 raises, $7.8M in all. Filings say how much was sold and to how many investors; they never name the investors. - Jul 2023 **$3.4M** UK share allotment - Dec 2021 **$4.4M** UK share allotment ## Founders and team From Alethio Therapeutics's own website: 1 founder, 7 on the team. **Prof. Beth Psaila** Founder and Director - **Dr Rohit Batta** CEO - **Dr Mark Throsby** Non-Executive Director - **Dr Sally Dewhurst** OSE Representative and Director - **Dr Suman Shirodkar** Non-Executive Director - **Joe Tancock** Operations Manager - **Mike Grey** Chair - **Rafael Maciel Ioris** Screening and antibody characterisation platform lead ## Who was in which round The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led. **Seed** 2021 **Seed** 2023 **Series A** 2026 [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) L [Sofinnova Partners](https://millionrounds.com/fund/sofinnova-partners) L [Oxford Science Enterprises](https://millionrounds.com/fund/oxford-science-enterprises) [University of Oxford](https://millionrounds.com/fund/university-of-oxford) [Cancer Research Horizons](https://millionrounds.com/fund/cancer-research-ho) ## Everyone who backed them [RA Capital Management](https://millionrounds.com/fund/ra-capital-management) Private equity **1** round, led 1 [Sofinnova Partners](https://millionrounds.com/fund/sofinnova-partners) VC firm **1** round, led 1 [Oxford Science Enterprises](https://millionrounds.com/fund/oxford-science-enterprises) VC firm **1** round [University of Oxford](https://millionrounds.com/fund/university-of-oxford) Investment firm **1** round [Cancer Research Horizons](https://millionrounds.com/fund/cancer-research-ho) VC firm **1** round Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=alethio-therapeutics). ## Quick answers about Alethio Therapeutics ### Who invested in Alethio Therapeutics? Alethio Therapeutics's investors include RA Capital Management, Sofinnova Partners, Oxford Science Enterprises, University of Oxford and Cancer Research Horizons. RA Capital Management led its latest round. ### How much has Alethio Therapeutics raised? Alethio Therapeutics has raised $98M across 3 rounds since 2021. ### When did Alethio Therapeutics last raise? Alethio Therapeutics's most recent round was a Series A of $90M in Nov 2026, led by RA Capital Management. ### What was Alethio Therapeutics's biggest round? Its most recent round, $90M in Nov 2026, is also its largest on record. ### Who backed Alethio Therapeutics first? Alethio Therapeutics's first round on record, in Nov 2026, was backed by RA Capital Management, Sofinnova Partners and Oxford Science Enterprises and 2 others. ### What stage is Alethio Therapeutics at? Alethio Therapeutics's latest named round is a Series A, in Nov 2026. ### Where is Alethio Therapeutics based? Alethio Therapeutics is based in the United Kingdom. ### Who led Alethio Therapeutics's rounds? RA Capital Management led the Series A in 2026. ## Companies like Alethio Therapeutics In the same sector, and raised in the last eighteen months. [**T-Therapeutics** $279M · Nov 2026](https://millionrounds.com/company/t-therapeutics)[**bit.bio** $264M · Nov 2026](https://millionrounds.com/company/bit-bio)[**1nhaler** $7.4M · Nov 2026](https://millionrounds.com/company/1nhaler)[**BioOrbit** $13M · Oct 2026](https://millionrounds.com/company/bioorbit)[**SAVA** $21M · Oct 2026](https://millionrounds.com/company/sava)[**GLORIAH** $800K · Oct 2026](https://millionrounds.com/company/gloriah) ## Find investors like these Search every investor by what they have actually funded, then narrow to your stage and market. Free. Open the investor searchOr these rounds in the app